Filing Details
- Accession Number:
- 0001104659-18-070832
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-30 16:17:11
- Reporting Period:
- 2018-11-29
- Accepted Time:
- 2018-11-30 16:17:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1720893 | Bioxcel Therapeutics Inc. | BTAI | Pharmaceutical Preparations (2834) | 821386754 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1733387 | Krishnan Nandabalan | C/O Bioxcel Therapeutics, Inc. 555 Long Wharf Drive New Haven CT 06511 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-29 | 1,000 | $4.92 | 1,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- By Krishnan Nandabalan and Suganthi Balasubramanian JTWROS
Billionaire Hedge Funds
